NHO Hokkaido Cancer Center

Sapporo 003-0804

2 studies enrolling now · 4 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Endometrial Cancer, Metastatic Breast Cancer, Ovarian Cancer

Studies at this site

• Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer — Recruiting now
• Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) — Recruiting now
• Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) — Completed
• Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer — Completed